Pulmonologists and intensivists: "two hearts are better than one" Respiratory Intensive Care Assembly contribution to the celebration of 20 years of the ERS, Nava S, Pelosi P. Eur Respir J 2010; 35: 463-466 | |
Neutrophils in chronic inflammatory airway diseases: can we target them and how? Gernez Y, Tirouvanziam R, Chanez P. Eur Respir J 2010; 35: 467-469 | |
Stress failure and high-altitude pulmonary oedema: mechanistic insights from physiology Hopkins S. R. Eur Respir J 2010; 35: 470-472 | |
Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty? Torres A, Menendez R. Eur Respir J 2010; 35: 473-474 | |
Management of tuberculosis in HIV infection: where T-cells matter Sester M, Giehl C, Sester U, Meyerhans A. Eur Respir J 2010; 35: 475-476 | |
Stereology: a bridge to a better understanding of lung structure and function Brusasco V, Dinh-Xuan A. T. Eur Respir J 2010; 35: 477-478 | |
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Pechoux C, Mutti L, Pairon J-C, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W. Eur Respir J 2010; 35: 479-495 | |
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Vancheri C, Failla M, Crimi N, Raghu G. Eur Respir J 2010; 35: 496-504 | |
HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reduction Curjuric I, Imboden M, Schindler C, Downs S. H, Hersberger M, Liu S. L. J, Matyas G, Russi E. W, Schwartz J, Thun G. A, Postma D. S, Rochat T, Probst-Hensch N. M, the SAPALDIA team Eur Respir J 2010; 35: 505-514 | |
Rapid reduction in hospitalisations after an intervention to manage severe asthma Souza-Machado C, Souza-Machado A, Franco R, Ponte E. V, Barreto M. L, Rodrigues L. C, Bousquet J, Cruz A. A. Eur Respir J 2010; 35: 515-521 | |
Differential gene expression and cytokine production from neutrophils in asthma phenotypes Baines K. J, Simpson J. L, Bowden N. A, Scott R. J, Gibson P. G. Eur Respir J 2010; 35: 522-531 | |
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study Briggs A. H, Glick H. A, Lozano-Ortega G, Spencer M, Calverley P. M. A, Jones P. W, Vestbo J, on behalf of the TOwards a Revolution in COPD Health (TORCH) investigators Eur Respir J 2010; 35: 532-539 | |
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Eagan T. M. L, Ueland T, Wagner P. D, Hardie J. A, Mollnes T. E, Damas J. K, Aukrust P, Bakke P. S. Eur Respir J 2010; 35: 540-548 | |
Atrophy and hypertrophy signalling in the diaphragm of patients with COPD Testelmans D, Crul T, Maes K, Agten A, Crombach M, Decramer M, Gayan-Ramirez G. Eur Respir J 2010; 35: 549-556 | |
Prevention of panic attacks and panic disorder in COPD Livermore N, Sharpe L, McKenzie D. Eur Respir J 2010; 35: 557-563 | |
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects Holz O, Khalilieh S, Ludwig-Sengpiel A, Watz H, Stryszak P, Soni P, Tsai M, Sadeh J, Magnussen H. Eur Respir J 2010; 35: 564-570 | |
Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial Spencer L. M, Alison J. A, McKeough Z. J. Eur Respir J 2010; 35: 571-577 | |
Long-term effects of a partially supervised conditioning programme in cystic fibrosis Hebestreit H, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Schenk T, Posselt H-G, Kriemler S. Eur Respir J 2010; 35: 578-583 | |
Stress failure plays a major role in the development of high-altitude pulmonary oedema in rats Bai C, She J, Goolaerts A, Song Y, Shen C, Shen J, Hong Q. Eur Respir J 2010; 35: 584-591 | |
Shift in sleep apnoea type in heart failure patients in the CANPAP trial Ryan C. M, Floras J. S, Logan A. G, Kimoff R. J, Series F, Morrison D, Ferguson K. A, Belenkie I, Pfeifer M, Fleetham J, Hanly P. J, Smilovitch M, Arzt M, Bradley T. D, for the CANPAP Investigators Eur Respir J 2010; 35: 592-597 | |
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors von Baum H, Welte T, Marre R, Suttorp N, Ewig S, for the CAPNETZ study group Eur Respir J 2010; 35: 598-615 | |
Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis? Chang K. C, Leung C. C, Yew W. W, Lau T. Y, Leung W. M, Tam C. M, Lam H. C, Tse P. S, Wong M. Y, Lee S. N, Wat K. I, Ma Y. H. Eur Respir J 2010; 35: 606-613 | |
The impact of time on the systemic inflammatory response in pneumococcal pneumonia Calbo E, Alsina M, Rodriguez-Carballeira M, Lite J, Garau J. Eur Respir J 2010; 35: 614-618 | |
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection Leidl L, Mayanja-Kizza H, Sotgiu G, Baseke J, Ernst M, Hirsch C, Goletti D, Toossi Z, Lange C. Eur Respir J 2010; 35: 619-626 | |
Effect of manufacturer-inserted mask leaks on ventilator performance Louis B, Leroux K, Isabey D, Fauroux B, Lofaso F. Eur Respir J 2010; 35: 627-636 | |
Statins inhibit matrix metalloproteinase release from human lung fibroblasts Kamio K, Liu X. D, Sugiura H, Togo S, Kawasaki S, Wang X, Ahn Y, Hogaboam C, Rennard S. I. Eur Respir J 2010; 35: 637-646 | |
beta2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway Freund-Michel V. C, Birrell M. A, Giembycz M. A, Hele D. J, Haj-Yahia S, Belvisi M. G. Eur Respir J 2010; 35: 647-654 | |
Comparative gene expression profiling of post-natal and post-pneumonectomy lung growth Wolff J-C, Wilhelm J, Fink L, Seeger W, Voswinckel R. Eur Respir J 2010; 35: 655-666 | |
Pulmonary changes induced by trans,trans-2,4-decadienal, a component of cooking oil fumes Wang C-K, Chang L. W, Chang H, Yang C-H, Tsai M-H, Tsai H-T, Lin P. Eur Respir J 2010; 35: 667-675 | |
Therapeutic implications of the pathophysiology of COPD Macklem P. T. Eur Respir J 2010; 35: 676-680 | |
Rituximab-induced lung disease: a systematic literature review Liote H, Liote F, Seroussi B, Mayaud C, Cadranel J. Eur Respir J 2010; 35: 681-687 | |
Increased T-regulatory cells in lungs and draining lymph nodes in a murine model of COPD Demoor T, Bracke K. R, Joos G. F, Brusselle G. G. Eur Respir J 2010; 35: 688-689 | |
Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population Abubakar I, Story A, Lipman M, Bothamley G, van Hest R, Andrews N, Watson J. M, Hayward A. Eur Respir J 2010; 35: 689-692 | |
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis Allix-Beguec C, Fauville-Dufaux M, Stoffels K, Ommeslag D, Walravens K, Saegerman C, Supply P. Eur Respir J 2010; 35: 692-694 | |
Chronic interstitial pneumonitis in end-stage sarcoidosis Shigemitsu H, Oblad J. M, Sharma O. P, Koss M. N. Eur Respir J 2010; 35: 695-697 | |
The sinusitis-infertility syndrome: Young's saint, old devil Goeminne P. C, Dupont L. J. Eur Respir J 2010; 35: 698 | |
Submitting a manuscript Quanjer P. Eur Respir J 2010; 35: 699 | |
Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification Tsangaris I, Orfanos S, Bouros D. Eur Respir J 2010; 35: 700-701 | |
Predicting persistence of wheezing: one algorithm does not fit all Matricardi P. M, Illi S, Keil T, Wagner P, Wahn U, Lau S. Eur Respir J 2010; 35: 701-703 | |
Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension Raffestin B, Leroy M. Eur Respir J 2010; 35: 704-705 | |
From the authors: Naeije R, van de Borne P. Eur Respir J 2010; 35: 705 | |
From the authors: Wensel R. Eur Respir J 2010; 35: 706 | |
List of reviewers 2009
Eur Respir J 2010; 35: 707-713 | |
Medical Management of the Thoracic Surgery Patient Van Schil P.E. Eur Respir J 2010; 35: 714 | |